- Lobbying
- Andrew AND Jones
Lobbying Arrangements Results for 'Andrew Jones'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues related to accounting and auditing. Issues related to technology in government. H.R. 2670 - National Defense Authorization Act for Fiscal Year 2024 |
Deloitte LLP
|
FEDERAL STREET STRATEGIES, LLC | |||
Details Patient Access to drug treatment therapies; and drug cost and drug pricing reform. Oversight of the pharmaceutical industry and drug pricing. H.R.830 - HELP Copays Act S. 1375 - HELP Copays Act ... |
AbbVie, Inc.
|
FEDERAL STREET STRATEGIES, LLC | |||
Details Issues related to energy infrastructure investments and safety and security. Issues related to oil and gas prices Issues related to the Renewable Fuel Standard, the Clean Air Act, transportation i... |
American Fuel & Petrochemical Manufacturers (AFPM)
|
FEDERAL STREET STRATEGIES, LLC | |||
Details H.R. 2415 / S. 1184, Treat and Reduce Obesity Act of 2013. |
Eisai, Inc.
|
PODESTA GROUP, INC. | |||
Details CMS payment policy. |
Vital Care, Inc.
|
PODESTA GROUP, INC. | |||
Details Medicare Parts D and B payment issues CMMI Medicare Part B proposed demonstration Senate HELP biomedical innovation/H.R. 6 - 21st Century Cures Act Cancer Moonshot Initiative |
EMD SERONO, INC.
|
PODESTA GROUP, INC. | |||
Details Enhance visibility of golf industry in Washington, D.C., monitor legislation impacting golf-related small businesses, and seek introduction of legislation beneficial to the golf industry. H.R. 2137... |
We Are Golf
|
PODESTA GROUP, INC. | |||
Details Auto industry issues (including sharing information about GM facilities, products, community programs, progress on GM restructuring, and responding to congressional inquiries concerning GM restruct... |
General Motors Company
|
PODESTA GROUP, INC. | |||
Details Center for Medicare and Medicaid Services proposed rules. H.R. 4302, Protecting Access to Medicare Act of 2014. Payment for home health services. Program integrity issues. |
Partnership for Quality Home Healthcare
|
PODESTA GROUP, INC. | |||
Details FDA modernization policy issues Reauthorization of newborn screening programs General issues related to rare disease and orphan drugs General issues related to health equity in rare disease and ... |
AstraZeneca Pharmaceuticals LP
|
in-house lobbying | |||
Details Issues related to internet competition; Internet of Things; data privacy; encryption; data breach; cybersecurity; telecommunications and broadband; and artificial intelligence. Issues related to in... |
MICROSOFT CORP
|
Monument Advocacy | |||
Details Proposals related to ownership of unclaimed savings bonds. Proposals to allow advance refunding of tax exempt municipal bonds; H.R. 1837, "Investing in Our Communities Act". Proposals related to in... |
NATIONAL ASSN. OF STATE TREASURERS (NAST)
|
Williams and Jensen, PLLC | |||
Details Issues relating to interchange fees on electronic payments; credit card interchange proposals; issues relating to financial literacy; issues relating to payment innovation and card technology; iss... |
VISA
|
Williams and Jensen, PLLC | |||
Details General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. General education about federal policies impac... |
Sanofi, U.S.
|
Williams and Jensen, PLLC | |||
Details Policies related to H.R. 1628, American Healthcare Act of 2017; General education about policies that impact pharmaceutical development approval and reimbursement; General education about FDA appro... |
Shire Pharmaceuticals LLC formerly known as Shire Regenerative Medicine
|
Williams and Jensen, PLLC | |||
Details Animal health , issues impacting medicines and vaccines for animals; ADUFA Reauthorization. (H.R. 1418; S. 1844, H.R. 5860). Monitor issues related to general corporate taxation; issues related to ... |
Zoetis
|
Williams and Jensen, PLLC | |||
Details Medicare Part B and D payment and coding issues. Prescription drug value issues. CMMI Medicare Part B proposed demonstration Senate HELP biomedical innovation/H.R. 6 - 21st Century Cures Act Cancer... |
AMGEN
|
PODESTA GROUP, INC. | |||
Details Export-import bank. H.R. 1865; S. 2293. H.R. 748, CARES Act Public Law No: 116-136; COVID-19 relief proposals. Defense spending levels. H.R. 748, CARES Act Public Law No: 116-136; COVID-19 relie... |
General Electric Company (previously reported as GE Aviation)
|
Williams and Jensen, PLLC | |||
Details H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions - antibiotic resistance). H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug ... |
Cubist Pharmaceuticals, Inc.
|
PODESTA GROUP, INC. | |||
Details Matters related to access to and pricing of plasma derived products and matters affecting the Orphan Drug Act and therapies for rare diseases. Matters affecting plasma donation and potential plasma... |
Plasma Protein Therapeutics Association
|
Williams and Jensen, PLLC | |||
Details Issues related to autonomous vehicles Cybersecurity Issues related to data sharing and data privacy Issues related to vehicle connectivity and telematics Issues related to automotive safety Issues ... |
FORD MOTOR COMPANY
|
in-house lobbying | |||
Details Defense research, development and procurement. |
GENERAL DYNAMICS
|
PODESTA GROUP, INC. | |||
Details Department of Defense Appropriations; Department of the Interior, Environment, and Related Agencies Appropriations; Department of State, Foreign Operations, and Related Programs Appropriations. Exp... |
LOCKHEED MARTIN CORPORATION
|
PODESTA GROUP, INC. | |||
Details Health care issues including Medicare's long-term financial health and drivers of health insurance premium changes, and comments on proposed legislation to add a long-term care benefit to the Medic... |
American Academy of Actuaries
|
in-house lobbying | |||
Details Issues related to the coverage of spiritual care. H.R. 2061 / S. 352 - EACH Act. |
Christian Science Committee on Publication
|
PODESTA GROUP, INC. | |||
Details Issues related to scientific, technical, and medical publishing. S.1701/HR 3427 - Fair Access to Science and Technology Research Act of 2017. Sec. 1940 of the Social Security Act. S. 760 - Open, Pu... |
RELX Inc.
|
PODESTA GROUP, INC. | |||
Details Issues related to broadband infrastructure, spectrum management, implementation of the Infrastructure Investment and Jobs Act; and issues related to undersea cable infrastructure. Issues related to... |
Ciena Corporation
|
Monument Advocacy | |||
Details STEM education. Cybersecurity and defense information technology. Department of Defense/Veterans' Affairs health records. H.R.2810/S. 1519 - National Defense Authorization Act for Fiscal Year 2018 ... |
Oracle Corporation
|
PODESTA GROUP, INC. | |||
Details Policies to ensure an adequate supply of blood plasma; Drug safety and drug counterfeiting; Policies affecting pre-existing condition protections; Drug importation; Policies impacting the U.S. res... |
Takeda Pharmaceuticals America, Inc.
|
Williams and Jensen, PLLC | |||
Details National Defense Authorization Act for Fiscal Year 2024, H.R. 2670 / S. 2226, Fiscal Year 2024 Department of Defense Appropriations Act, H.R. 4365 / S. 2587 (issues related to ship programs, C-130/... |
ROLLS-ROYCE NORTH AMERICA AND ITS AFFILIATES
|
in-house lobbying | |||
Details Legislative and regulatory issues regarding Medicaid managed care; Medicare Advantage issues. Implementation of COVID legislation. Policies impacting U.S. address to the Covid-19 pandemic, "Inflat... |
Elevance Health, Inc. (formerly reported as Anthem, Inc.)
|
Williams and Jensen, PLLC | |||
Details Issues relating to domestic and international corporate tax: S.866, American Innovation and Jobs Act; H.R. 2673, American Innovation and R&D Competitiveness Act of 2023. Issues relating to DOD tech... |
Dell Technologies Inc.
|
in-house lobbying | |||
Details General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. IPI drug pricing propos... |
PhRMA
|
Williams and Jensen, PLLC | |||
Details No bill number - Funding for IDEA Part B & C: Advocate for increased funding. No bill number - Funding for IDEA Part D - Personnel Prep. Grants: Advocate for increased funding. No bill number - ... |
The American Occupational Therapy Association, Inc. (AOTA)
|
in-house lobbying | |||
Details Issues related to the availability and appropriate uses of commercial spectrum, the integrity and security of commercial networks, appropriate regulatory framework for Internet, communications serv... |
AT&T Services, Inc. and its affiliates
|
in-house lobbying | |||
Details Medicare Advantage (Part C) and Prescription Drug (Part D) programs including: quality measures and star ratings; third-party marketing tactics and broker compensation; prescription drug costs; ris... |
Alliance of Community Health Plans, Inc.
|
in-house lobbying | |||
Details International and domestic tax issues. General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, an... |
Eli Lilly & Company
|
Williams and Jensen, PLLC | |||
Details General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; Medicare Part D; drug importation; and drug shortages. Drug ... |
PFIZER
|
Williams and Jensen, PLLC | |||
Details FY24 National Defense Authorization Act (H.R. 2670; S. 2226); FY24 Defense Appropriations Act (H.R. 4365; S. 2587); FY24 Military Construction, Veterans Affairs, and Related Agencies Appropriations... |
NORTHROP GRUMMAN CORPORATION
|
in-house lobbying | |||
Details (1)Issues related to Public Law 111-148 - The Patient Protection and Affordable Care Act (2)Issues related to Public Law 111-152 - Health Care and Education Reconciliation Act of 2010 (3)Issues rel... |
AETNA INC.
|
in-house lobbying | |||
Details 2023 Farm Bill GIPSA - Farm Fair practices rule AMS - Mandatory Price Reporting CFTC price volatility oversight Cell-Base proteins Coronavirus Food Assistance Program Commodity Credit Corporation C... |
AMERICAN FARM BUREAU FED
|
in-house lobbying | |||
Details Insulin Out of Pocket Costs; Covid Therapeutics; Generics Access; Gene Therapy S. 150 - Affordable Prescriptions for Patients Act of 2023 A bill to amend the Federal Trade Commission Act to prohi... |
Blue Cross and Blue Shield Association
|
in-house lobbying | |||
Details H.R. 766, Preventive Health Savings Act, all provisions S. 114, Preventive Health Savings Act, all provisions H.R. 5525, Continuing Appropriations and Border Security Enhancement Act, 2024, all pro... |
American Medical Association
|
in-house lobbying | |||
Details No bill number. Discussed the Mental Health Parity and Addiction Equity Act of 2008. No bill number. Discussed commercial health insurance provider networks. H.R. 5378, the Lower Costs, More Tr... |
AARP
|
in-house lobbying | |||
Details H.R. 485 - Protecting Health Care For All Patients Act of 2023 - Rep. McMorris Rodgers, Cathy - federal programs using prices based on quality-adjusted life years H.R. 824 - Telehealth Benefit Exp... |
AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
|
in-house lobbying | |||
Details H.R. 2670/S. 2226, National Defense Authorization Act for Fiscal Year 2024 H.R. 6131, Commercial Space Act of 2023 Draft legislation regarding Department of Commerce Office of Space Commerce missi... |
Chamber of Commerce of the U.S.A.
|
in-house lobbying | |||
Details H.R.132 - To amend the Robert T. Stafford Disaster Relief and Emergency Assistance Act to include algal blooms in the definition of a major disaster, and for other purposes. (Vern Buchanan, R-FL-16... |
NATIONAL ASSOCIATION OF MUTUAL INSURANCE COMPANIES
|
in-house lobbying |